Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Kavanaugh

Showing results (81-90 of 381) with videos related to

Pageof 39
Sort By:
Rheumatology (Oxford, England)|October 17, 2012
Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trialRoy Fleischmann, Arthur Kavanaugh, Joseph Smolen
Current Allergy and Asthma Reports|August 9, 2003
Secondary immune deficiencies associated with biological therapeuticsSusan J Lee, Parekha Yedla, Arthur Kavanaugh
Arthritis and Rheumatism|August 1, 2009
Treatment disparity related to race/ethnicity and education in rheumatoid arthritis patients: comment on the article by Constantinescu et alSusan J Lee, Joel Kremer, Arthur Kavanaugh, et al.
Current Opinion in Rheumatology|June 10, 2006
Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritisArthur Kavanaugh, Zuhre Tutuncu, Teresa Catalan-Sanchez
Clinical and Experimental Rheumatology|October 17, 2015
An overview of low disease activity and remission in psoriatic arthritisEnnio Lubrano, Fabio Massimo Perrotta, Arthur Kavanaugh
Immunology|July 4, 2013
Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritisBruce W Kirkham, Arthur Kavanaugh, Kristian Reich
The American Journal of Medicine|October 29, 2002
Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritisJohn B Wong, Gurkirpal Singh, Arthur Kavanaugh
Best Practice & Research. Clinical Rheumatology|August 7, 2007
Electronic and computer-generated patient questionnaires in standard careSusan J Lee, Arthur Kavanaugh, Leslie Lenert
Arthritis Care & Research|January 11, 2012
Predicting future response to certolizumab pegol in rheumatoid arthritis patients: features at 12 weeks associated with low disease activity at 1 yearJeffrey R Curtis, Kristel Luijtens, Arthur Kavanaugh
Rheumatology and Therapy|October 18, 2016
Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) SurveyArthur Kavanaugh, Philip Helliwell, Christopher T Ritchlin
Pageof 39

Showing results (81-90 of 381) with videos related to

Sort By:
Pageof 39
Rheumatology (Oxford, England)|October 17, 2012
Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trialRoy Fleischmann, Arthur Kavanaugh, Joseph Smolen
Current Allergy and Asthma Reports|August 9, 2003
Secondary immune deficiencies associated with biological therapeuticsSusan J Lee, Parekha Yedla, Arthur Kavanaugh
Arthritis and Rheumatism|August 1, 2009
Treatment disparity related to race/ethnicity and education in rheumatoid arthritis patients: comment on the article by Constantinescu et alSusan J Lee, Joel Kremer, Arthur Kavanaugh, et al.
Current Opinion in Rheumatology|June 10, 2006
Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritisArthur Kavanaugh, Zuhre Tutuncu, Teresa Catalan-Sanchez
Clinical and Experimental Rheumatology|October 17, 2015
An overview of low disease activity and remission in psoriatic arthritisEnnio Lubrano, Fabio Massimo Perrotta, Arthur Kavanaugh
Immunology|July 4, 2013
Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritisBruce W Kirkham, Arthur Kavanaugh, Kristian Reich
The American Journal of Medicine|October 29, 2002
Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritisJohn B Wong, Gurkirpal Singh, Arthur Kavanaugh
Best Practice & Research. Clinical Rheumatology|August 7, 2007
Electronic and computer-generated patient questionnaires in standard careSusan J Lee, Arthur Kavanaugh, Leslie Lenert
Arthritis Care & Research|January 11, 2012
Predicting future response to certolizumab pegol in rheumatoid arthritis patients: features at 12 weeks associated with low disease activity at 1 yearJeffrey R Curtis, Kristel Luijtens, Arthur Kavanaugh
Rheumatology and Therapy|October 18, 2016
Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) SurveyArthur Kavanaugh, Philip Helliwell, Christopher T Ritchlin
Pageof 39